Purchase Order 75D30126P21454

<p>The CDC Pittsburgh issued a purchase order to Beacon Scientific Inc. for $234,000.00 on August 19, 2026, for integrase inhibitor lateral flow devices under Executive Order 14398. Work is performed in San Diego, California. The order carries a firm fixed price and has an ultimate completion date of October 20, 2027.</p>

<p>CDC Pittsburgh awarded a purchase order to Roche Diagnostics Corporation for $572,044.24 on July 17, 2024 to provide maintenance services for a COBAS HIV instrument with operations support. The order carries a firm fixed-price structure and runs through September 4, 2028. Place of performance is Indianapolis, Indiana.</p>

<p>CDC Pittsburgh awarded a purchase order to Illumina, Inc. for $211,080.73 in five-year maintenance services under Executive Order 14398, with an award date of September 15, 2022 and ultimate completion date of September 18, 2026. No set-aside was used. Place of performance is Atlanta, Georgia. The order is priced on a firm fixed price basis.</p>

<p>CDC Pittsburgh awarded a purchase order to Roche Diagnostics Corporation for $130,151.30 on September 12, 2026, with an ultimate completion date of September 11, 2027. The order carries firm fixed-price terms and no set-aside.</p> <p>Performance occurs in Atlanta, Georgia. The purchase order covers in vitro diagnostic equipment, reagents, laboratory instruments, or associated medical products supplied under Roche Diagnostics' commercial catalog and GSA Schedule pricing.</p>

<p>CDC Pittsburgh awarded a purchase order to Quest Diagnostics Incorporated for delivery of deidentified nasopharyngeal specimens, valued at $93,600.00, on August 14, 2024. Work is performed at Halethorpe, Maryland. The order carries a firm fixed price structure with an ultimate completion date of August 13, 2026. This is a commercial acquisition under no set-aside, issued in execution of Executive Order 14398.</p>

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $24,069.52 purchase order to Fujirebio US, Inc. for INNO-LIA HIV I/II SCORE tests. Fujirebio US, Inc. will deliver the tests from its division location in Chamblee, Georgia under the firm fixed price contract, which runs from July 20 through September 30, 2023. No set aside designation or subcontractors were indicated. The Centers for Disease Control and Prevention works to protect...

<p>CDC Pittsburgh awarded a purchase order to Becton, Dickinson and Company (BD Biosciences division) valued at $86,150.40 on July 4, 2026, with performance completion by August 31, 2028. Work is performed in Atlanta, Georgia. The order is firm fixed price with no small business set-aside. The specific scope of supplies or services is not detailed in the award documentation.</p>

<p>The Centers for Disease Control and Prevention, Atlanta (CDC Pittsburgh) issued a purchase order to Beth Israel Deaconess Medical Center, Inc. for $8,118.00 on July 1, 2026, for an EO 14398 HIV neutralizing antibody assay with an ultimate completion date of April 30, 2027. Work is performed in Boston, Massachusetts. The order is firm fixed price with no set-aside designation applied.</p>

<p>The CDC Pittsburgh issued a purchase order to Dallas County Texas on August 31, 2026, valued at $95,276.00, for lateral flow test results in support of Executive Order 14398. Performance will occur in Dallas, Texas (75202), with an ultimate completion date of July 28, 2028. The order is firm fixed price with no set-aside designation.</p>

<p>CDC Pittsburgh awarded a purchase order to Illumina, Inc. valued at $236,726.60 for a service agreement under Executive Order 14398, with an award date of September 1, 2023 and ultimate completion date of August 31, 2026. No set-aside was used. Work is performed in San Diego, California 92122. The order is priced on a firm fixed price basis. The specific requirements and scope of the service agreement are not detailed in the award document.</p>